Comprehensive Care of Sleep Disordered Breathing

Summary

The Comprehensive Care of Sleep Disordered Breathing study (Care-SDB) is a prospective, multi-center, registry-based cohort study designed to investigate the integrated management of sleep-disordered breathing (SDB). The investigators aim to establish a nationwide SDB cohort and biobank to identify prognostic biomarkers, explore pathogenic mechanisms, and evaluate optimal treatment models. A total of 11,100 adult patients with recent sleep monitoring will be enrolled and followed longitudinally for up to 5 years. Data collection, including clinical outcomes and major adverse events, will be managed via a unified Electronic Data Capture platform. The results from Care-SDB are expected to provide critical evidence-based guidance for the risk stratification, standardized intervention, and personalized management of patients with sleep-disordered breathing.

Conditions

• Sleep Disordered Breathing (SDB)

Interventions

OTHER

Clinical Management for SDB

Participants receive standard clinical care and management for sleep-disordered breathing according to established clinical guidelines. This may include, but is not limited to, CPAP therapy, lifestyle modifications, oral appliances, or other medical interventions as determined by the treating physician.

Sponsors & Collaborators

• Beijing Hospital

  collaborator OTHER_GOV

• Second Xiangya Hospital of Central South University

  collaborator OTHER

• Peking University Hospital of Stomatology

  collaborator OTHER

• Shantou University Medical College

  collaborator OTHER

• Shanghai Institute of Hypertension

  collaborator OTHER

• First Affiliated Hospital of Fujian Medical University

  collaborator OTHER

• Beijing Tiantan Hospital

  collaborator OTHER

• Beijing Jishuitan Hospital

  collaborator OTHER

• Beijing Friendship Hospital

  collaborator OTHER

• West China Hospital

  collaborator OTHER

• Beijing Chao Yang Hospital

  collaborator OTHER

• Beijing Anzhen Hospital

  lead OTHER

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2026-01-01

Primary Completion

2028-12-31

Completion

2029-01-01

Countries

• China

Study Locations